These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28490335)

  • 1. ING5 suppresses breast cancer progression and is regulated by miR-24.
    Cui S; Liao X; Ye C; Yin X; Liu M; Hong Y; Yu M; Liu Y; Liang H; Zhang CY; Chen X
    Mol Cancer; 2017 May; 16(1):89. PubMed ID: 28490335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
    Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
    J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
    Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
    Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The down-regulated ING5 expression in lung cancer: a potential target of gene therapy.
    Zhao S; Yang XF; Shen DF; Gao Y; Shi S; Wu JC; Liu HX; Sun HZ; Su RJ; Zheng HC
    Oncotarget; 2016 Aug; 7(34):54596-54615. PubMed ID: 27409347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ING5 overexpression upregulates miR-34c-5p/Snail1 to inhibit EMT and invasion of lung cancer cells.
    Yang J; Liu X; Sun Y; Zhang X; Zhao Y; Zhang H; Mei Q; Meng J; Zhang F; Zhang T
    Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):809-817. PubMed ID: 37249332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.
    Yu H; Xing H; Han W; Wang Y; Qi T; Song C; Xu Z; Li H; Huang Y
    Tumour Biol; 2017 May; 39(5):1010428317701647. PubMed ID: 28459205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating brain-derived neurotrophic factor.
    Gao B; Hao S; Tian W; Jiang Y; Zhang S; Guo L; Zhao J; Zhang G; Yan J; Luo D
    J Gene Med; 2017 Dec; 19(12):. PubMed ID: 27813254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway.
    Wang Y; Tan J; Li J; Chen H; Wang W
    Technol Cancer Res Treat; 2021; 20():15330338211039940. PubMed ID: 34520285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma.
    Ye P; Ke X; Zang X; Sun H; Dong Z; Lin J; Wang L; Liu W; Miao G; Tan Y; Tong W; Xiao H; Gao L
    Biomed Pharmacother; 2018 May; 101():219-227. PubMed ID: 29494959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-193 promotes cell proliferation and invasion by ING5/PI3K/AKT pathway of triple-negative breast cancer.
    Xu JH; Zhao JX; Jiang MY; Yang LP; Sun ML; Wang HW
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3122-3129. PubMed ID: 32271430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
    Zheng M; Sun X; Li Y; Zuo W
    Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid.
    Wu JC; Jiang HM; Yang XH; Zheng HC
    Cancer Med; 2018 Sep; 7(9):4554-4569. PubMed ID: 30091530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.
    Li Y; Deng H; Lv L; Zhang C; Qian L; Xiao J; Zhao W; Liu Q; Zhang D; Wang Y; Yan J; Zhang H; He Y; Zhu J
    Oncotarget; 2015 Apr; 6(12):10195-206. PubMed ID: 25991669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.